CD8A and neoplasm: Using previously established β2m−/− 6694c2 pancreatic cancer cells62 (Figure 5E), we confirmed that even in the absence of direct CD8+ T cell recognition, d106S-IL12 could elicit stable tumor control of highly refractive pancreatic cancer (Figures 5F and 5G).